INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) if necessary.

1. Company Name and Address4. EPA ProductRegistration

United States Environmental Protection 

Agency Washington, D.C. 20460

DATA CALL-IN RESPONSE

3. Date and Type of DCI 

GENERIC22-Sep-2011ID # GDCI-02500

2. Case # and Name

0139 Coal Tar/CreosoteChemical # and Name 025004

Coal tar creosote

5. I wish to cancel this product registration voluntarily

6. Generic Data 7. Product Specific Data

7a. My product is an MUP andI agree to satisfy the MUP requirements on the attached form entitled "Requirements Status and Registrant's Response."

6a. I am claiming a GenericData Exemption because I obtain the active ingredient from the source EPA registration number listed below.

6b. I agree to satisfy Generic Data requirements as indicated on the attached form entitled "Requirements Status and Registrant's Response."

N.A. 

10. Name of Company 11. Phone Numb

9. Date 8. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that any knowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.

Signature and Title of Company's Authorized Representative__________________________________
Coal tar creosote

INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) if necessary.

4. Guideline Requirement Number

5. Study Title

1. Company Name and Address

United States Environmental Protection 

Agency Washington, D.C. 20460

REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE

3. Date and Type of DC

ID #GENERIC22-Sep-2011

GDCI-02500

2. Case # and Name

0139 Coal Tar/Creosote

Chemical # and Name 025004

7. Test Substance

6. Use Pattern

P

R

O

T

O

C

O

L

Progress

Reports

1 2 3

Applicator Exposure Data Requirements (Antimicrobial)

875.1100 Dermal exposure--outdoor (2 ,3 ,4 ,24) BB 875.1200 Dermal exposure--Indoor (5 ,6 ,7 ,25) BB 875.1300 Inhalation exposure--outdoor (8 ,9 ,10 ,26) BB 

(11 ,12 ,13,14 ,27)

875.1400 Inhalation exposure--indoor BB 875.1600 Application exposure monitoring data reporting (15 ,22) BB 875.1700 Product Use Information (16) BB 

Environmental Fate Data Requirements (Antimicrobial)

(17 ,18 ,19,20 ,23)

SS-Leaching Leaching study BB SS-SedimentConc Sediment concentration, Aquatic structures (1 ,21) BB 

12. Name of Company 13. Phone NumbSignature and Title of Company's Authorized Representative__________________________________10. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that any knowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law

11. Date
Case # and Name: 0139 Coal Tar/Creosote

DCI Number: GDCI-025004-30249

Footnotes: [The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Key:

United States Environmental Protection

Agency Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

Use Categories Key:

BB - Wood preservatives

1 Field study or simulated study for aquatic structures, sediment concentration data for warm southern conditions, and water column concentrations from m

northern conditions cannot be used to satisfy this requirement. A protocol must be submitted for review and approval by the Agency prior to initiating this submitted to the Agency within 90 days of receipt of this DCI.

2 The Agency will require application exposure data beyond the required product use information (Guideline 875.1700) if at least one of the following expo

following toxicity criteria are met by the TEP, TGAI, or one of the pesticide's metabolites: (i) Exposure criteria. (A) Dermal exposure is likely to occur durto occur during use. (C) Adequate surrogate exposure data (e.g. PHED) to estimate the magnitude of exposure for a particular work activity with an acceunavailable. (ii) Toxicity criteria. (A) The acute dermal LD50 is less than or equal to 200 mg/kg (i.e., Toxicity Category I (Guideline 870.1200) as per 40 LC50 (Guideline 870.1300) is less than or equal to 0.05 mg/liter (i.e., 4-hour exposure, Toxicity Category I) and the TGAI has a vapor pressure greater thoutdoors or any indoor application regardless of the vapor pressure. (C) The pesticide is found to be a neurotoxicant (Guideline 870.6200). (D) The pesttoxicant (Guidelines 870.3700 and 870.6300). (E) The pesticide is found to be a carcinogen (Guideline 870.4200). (F) The pesticide shows potential adas 90-day oral (Guideline 870.3100), 21-day repeated dermal toxicity (Guideline 870.3200), 90-day dermal toxicity (Guideline 870.3250), 90-day inhalatand fertility effects (Guideline 870.3800), and chronic feeding (Guideline 870.4100). (G) The pesticide is found to be a mutagen (Guidelines 870.5100 to (Guideline 870.7800). (H) Epidemiological or poisoning incidence data indicate adverse effects from handling the pesticide.

3 Required for outdoor uses when that is the primary use or if outdoor uses are expected to result in greater exposure than indoor uses.

4 Protocols must be submitted to the Agency for approval before initiating a study.5 The Agency will require application exposure data beyond the required product use information (Guideline 875.1700) if at least one of the following expo

following toxicity criteria are met by the TEP, TGAI, or one of the pesticide's metabolites: (i) Exposure criteria. (A) Dermal exposure is likely to occur durto occur during use. (C) Adequate surrogate exposure data (e.g. PHED) to estimate the magnitude of exposure for a particular work activity with an acceunavailable. (ii) Toxicity criteria. (A) The acute dermal LD50 is less than or equal to 200 mg/kg (i.e., Toxicity Category I (Guideline 870.1200) as per 40 LC50 (Guideline 870.1300) is less than or equal to 0.05 mg/liter (i.e., 4-hour exposure, Toxicity Category I) and the TGAI has a vapor pressure greater thoutdoors or any indoor application regardless of the vapor pressure. (C) The pesticide is found to be a neurotoxicant (Guideline 870.6200). (D) The pesttoxicant (Guidelines 870.3700 and 870.6300). (E) The pesticide is found to be a carcinogen (Guideline 870.4200). (F) The pesticide shows potential adas 90-day oral (Guideline 870.3100), 21-day repeated dermal toxicity (Guideline 870.3200), 90-day dermal toxicity (Guideline 870.3250), 90-day inhalatand fertility effects (Guideline 870.3800), and chronic feeding (Guideline 870.4100). (G) The pesticide is found to be a mutagen (Guidelines 870.5100 to (Guideline 870.7800). (H) Epidemiological or poisoning incidence data indicate adverse effects from handling the pesticide.

6 Protocols must be submitted to the Agency for approval before initiating a study.7 Required for indoor uses such as aquaria when the Agency determines such uses are likely to result in greater exposure than outdoor uses.
Case # and Name: 0139 Coal Tar/Creosote

DCI Number: GDCI-025004-30249

Footnotes: [The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Key:

United States Environmental Protection

Agency Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

Use Categories Key:

BB - Wood preservatives

8 The Agency will require application exposure data beyond the required product use information (Guideline 875.1700) if at least one of the following expo

following toxicity criteria are met by the TEP, TGAI, or one of the pesticide's metabolites: (i) Exposure criteria. (A) Dermal exposure is likely to occur durto occur during use. (C) Adequate surrogate exposure data (e.g. PHED) to estimate the magnitude of exposure for a particular work activity with an acceunavailable. (ii) Toxicity criteria. (A) The acute dermal LD50 is less than or equal to 200 mg/kg (i.e., Toxicity Category I (Guideline 870.1200) as per 40 LC50 (Guideline 870.1300) is less than or equal to 0.05 mg/liter (i.e., 4-hour exposure, Toxicity Category I) and the TGAI has a vapor pressure greater thoutdoors or any indoor application regardless of the vapor pressure. (C) The pesticide is found to be a neurotoxicant (Guideline 870.6200). (D) The pesttoxicant (Guidelines 870.3700 and 870.6300). (E) The pesticide is found to be a carcinogen (Guideline 870.4200). (F) The pesticide shows potential adas 90-day oral (Guideline 870.3100), 21-day repeated dermal toxicity (Guideline 870.3200), 90-day dermal toxicity (Guideline 870.3250), 90-day inhalatand fertility effects (Guideline 870.3800), and chronic feeding (Guideline 870.4100). (G) The pesticide is found to be a mutagen (Guidelines 870.5100 to (Guideline 870.7800). (H) Epidemiological or poisoning incidence data indicate adverse effects from handling the pesticide.

9 Required for outdoor uses when that is the primary use or if outdoor uses are expected to result in greater exposure than indoor uses.

10 Protocols must be submitted to the Agency for approval before initiating a study.11 The Agency will require application exposure data beyond the required product use information (Guideline 875.1700) if at least one of the following expo

following toxicity criteria are met by the TEP, TGAI, or one of the pesticide's metabolites: (i) Exposure criteria. (A) Dermal exposure is likely to occur durto occur during use. (C) Adequate surrogate exposure data (e.g. PHED) to estimate the magnitude of exposure for a particular work activity with an acceunavailable. (ii) Toxicity criteria. (A) The acute dermal LD50 is less than or equal to 200 mg/kg (i.e., Toxicity Category I (Guideline 870.1200) as per 40 LC50 (Guideline 870.1300) is less than or equal to 0.05 mg/liter (i.e., 4-hour exposure, Toxicity Category I) and the TGAI has a vapor pressure greater thoutdoors or any indoor application regardless of the vapor pressure. (C) The pesticide is found to be a neurotoxicant (Guideline 870.6200). (D) The pesttoxicant (Guidelines 870.3700 and 870.6300). (E) The pesticide is found to be a carcinogen (Guideline 870.4200). (F) The pesticide shows potential adas 90-day oral (Guideline 870.3100), 21-day repeated dermal toxicity (Guideline 870.3200), 90-day dermal toxicity (Guideline 870.3250), 90-day inhalatand fertility effects (Guideline 870.3800), and chronic feeding (Guideline 870.4100). (G) The pesticide is found to be a mutagen (Guidelines 870.5100 to (Guideline 870.7800). (H) Epidemiological or poisoning incidence data indicate adverse effects from handling the pesticide.

12 Required for outdoor uses when that is the primary use or if outdoor uses are expected to result in greater exposure than indoor uses.

13 Protocols must be submitted to the Agency for approval before initiating a study.14 Required for indoor uses such as aquaria when the Agency determines such uses are likely to result in greater exposure than outdoor uses.15 Data reporting and calculations are required when exposure data are submitted.
Case # and Name: 0139 Coal Tar/Creosote

DCI Number: GDCI-025004-30249

Footnotes: [The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Key:

United States Environmental Protection

Agency Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

Use Categories Key:

BB - Wood preservatives

16 Use information pertains to the methods of mixing, loading and applying the pesticide and associated work practices that will play an integral part in dete

pesticide handlers. Required product use information includes range and typical values for: Application rates; area treated per day and per year; timing aper year for private and professional handlers; exposure time per activity; types of handling equipment; type of clothing worn; geographical distribution of 

17 Sterile buffered distilled water and sterile synthetic seawater must be used for the antifoulant hydrolysis and leaching studies.

18 Data are required if exposure estimates from modeling (e.g., dilution factor model) indicate that active ingredient or principal transformation products are 

nontarget waters and when any of the following conditions apply: (i) Modeling indicates acute Estimated Environmental Concentrations (EECs) of active ingredient or principal transformation products in the aquatic envof any LC50/EC50 value determined in acute toxicity testing for aquatic vertebrates or invertebrates. (ii) Modeling indicates continuous, or chronic, Estimated Environmental Concentrations (EECs) of active ingredient or principal transformation products than or equal to 0.01 of any LC50/EC50 value determined in acute toxicity testing for aquatic vertebrates or invertebrates. (iii) Physicochemical properties of the compound indicate cumulative effects may occur (e.g., Kow is greater than or equal to 1,000). (iv) The active ingredient or principal transformation products are persistent in water (e.g., hydrolysis half-life in water is greater than 4 days).

19 Applicants must obtain approval of wood preservative leaching study protocols from the Agency prior to initiation of testing. The following methods or the

preservatives, the American Wood Preservers= Association=s Standard Method of Determining the Leachability of Wood Preservatives (E11-97); for ant

20 Please see 40 CFR Sections 158 and/or 161 for additional information.21 Please see 40 CFR Sections 158 and/or 161 for additional information.22 In accordance with 40 CFR 158.1020, OPPTS Guideline 875.1600 is required to accompany OPPTS Guidelines 875.1100 (Dermal Outdoor Exposure), 

875.1300 (Inhalation Outdoor Exposure), and 875.1400 (Inhalation Indoor Exposure). When all four GLNs are listed, the registrant is only required to peexposure and one inhalation exposure.

23 A protocol must be submitted for review and approval by the Agency prior to initiating this study. The draft protocol must be submitted to the Agency wit

24 Prior to initiation of the study, protocols must be submitted for review and approval by the Agency. Studies involving intentional exposure of human subj

EPA and then the Human Studies Review Board (HSRB) according to 40 CFR 26.1125. Examples of proposed human study research can be found in vStudies Review Board (http://www.epa.gov/osa/hsrb/index.htm). The draft protocol must be submitted to the Agency within 90 days of receipt of this DC

25 Prior to initiation of the study, protocols must be submitted for review and approval by the Agency. Studies involving intentional exposure of human subj

EPA and then the Human Studies Review Board (HSRB) according to 40 CFR 26.1125. Examples of proposed human study research can be found in vStudies Review Board (http://www.epa.gov/osa/hsrb/index.htm). The draft protocol must be submitted to the Agency within 90 days of receipt of this DC
Case # and Name: 0139 Coal Tar/Creosote

DCI Number: GDCI-025004-30249

Footnotes: [The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Key:

United States Environmental Protection

Agency Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

26 Prior to initiation of the study, protocols must be submitted for review and approval by the Agency. Studies involving intentional exposure of human subj

EPA and then the Human Studies Review Board (HSRB) according to 40 CFR 26.1125. Examples of proposed human study research can be found in v

Studies Review Board (http://www.epa.gov/osa/hsrb/index.htm). The draft protocol must be submitted to the Agency within 90 days of receipt of this DC

27 Prior to initiation of the study, protocols must be submitted for review and approval by the Agency. Studies involving intentional exposure of human subj

EPA and then the Human Studies Review Board (HSRB) according to 40 CFR 26.1125. Examples of proposed human study research can be found in vStudies Review Board (http://www.epa.gov/osa/hsrb/index.htm). The draft protocol must be submitted to the Agency within 90 days of receipt of this DC
United States Environmental Protection

Agency Washington, D.C. 20460

LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICE

Co. Nr. Company Name Agent For Address City & S

Case # and Name: 0139,Coal Tar/Creosote

61468 KOPPERS INC 436 SEVENTH AVENUE, K-1800 PITTSB